These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 11803863)

  • 21. Efficacy, tolerability, and rare side effects of tibolone treatment in postmenopausal women.
    Egarter C; Sator M; Berghammer P; Huber J
    Int J Gynaecol Obstet; 1999 Mar; 64(3):281-6. PubMed ID: 10366051
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cyclicity of breast tenderness and night-time vasomotor symptoms in mid-life women: information collected using the Daily Perimenopause Diary.
    Hale GE; Hitchcock CL; Williams LA; Vigna YM; Prior JC
    Climacteric; 2003 Jun; 6(2):128-39. PubMed ID: 12841883
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Confirmation of the efficacy of ERr 731 in perimenopausal women with menopausal symptoms.
    Kaszkin-Bettag M; Ventskovskiy BM; Solskyy S; Beck S; Hasper I; Kravchenko A; Rettenberger R; Richardson A; Heger PW
    Altern Ther Health Med; 2009; 15(1):24-34. PubMed ID: 19161045
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tibolone. KB 889, ORG OD 14, ORG OD14, Livial, Livifem, Boltin.
    Drugs R D; 1999 Mar; 1(3):225-7. PubMed ID: 10566032
    [No Abstract]   [Full Text] [Related]  

  • 25. Efficacy comparison of Pueraria mirifica (PM) against conjugated equine estrogen (CEE) with/without medroxyprogesterone acetate (MPA) in the treatment of climacteric symptoms in perimenopausal women: phase III study.
    Chandeying V; Sangthawan M
    J Med Assoc Thai; 2007 Sep; 90(9):1720-6. PubMed ID: 17957910
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Historical milestones in the development of tibolone (Livial®).
    Kloosterboer HJ
    Climacteric; 2011 Dec; 14(6):609-21. PubMed ID: 21942642
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The clinical use of a preparation based on phyto-oestrogens in the treatment of menopausal disorders.
    Russo R; Corosu R
    Acta Biomed; 2003 Dec; 74(3):137-43. PubMed ID: 15055018
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of leuprolide acetate plus tibolone in the treatment of severe premenstrual syndrome.
    Di Carlo C; Palomba S; Tommaselli GA; Guida M; Di Spiezio Sardo A; Nappi C
    Fertil Steril; 2001 Feb; 75(2):380-4. PubMed ID: 11172843
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tibolone: the way to beat many a postmenopausal ailments.
    Lazovic G; Radivojevic U; Marinkovic J
    Expert Opin Pharmacother; 2008 Apr; 9(6):1039-47. PubMed ID: 18377345
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical experience with venlafaxine in the treatment of hot flushes in women with a history of breast cancer.
    van Gool AR; Bannink M; Bontenbal M; Seynaeve C
    Neth J Med; 2005 May; 63(5):175-8. PubMed ID: 15952486
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Low-dose transdermal estradiol for symptomatic perimenopause.
    Shulman LP; Harari D
    Menopause; 2004; 11(1):34-9. PubMed ID: 14716180
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Motives for initiation, temporary discontinuation, and permanent discontinuation of hormone replacement therapy use among Norwegian women.
    Øren A
    Maturitas; 2009 Sep; 64(1):33-7. PubMed ID: 19720480
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of high-dose RU-486 treatment on climacteric complaints in hysterectomized postmenopausal women: a 6-week pilot study.
    Verhoeven MO; van der Mooren MJ; Coelingh Bennink HJ; van der Linden RF
    Eur J Obstet Gynecol Reprod Biol; 2004 Jul; 115(1):115-6. PubMed ID: 15223181
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy of the special extract ERr 731 from rhapontic rhubarb for menopausal complaints: a 6-month open observational study.
    Kaszkin-Bettag M; Beck S; Richardson A; Heger PW; Beer AM
    Altern Ther Health Med; 2008; 14(6):32-8. PubMed ID: 19043936
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The concept of selective action steroids].
    Jamin C
    Gynecol Obstet Fertil; 2000 Dec; 28(12):931-9. PubMed ID: 11192203
    [No Abstract]   [Full Text] [Related]  

  • 36. Effects of tibolone on lipoprotein(a) and HDL subfractions.
    Farish E; Barnes JF; Rolton HA; Spowart K; Fletcher CD; Hart DM
    Maturitas; 1994 Dec; 20(2-3):215-9. PubMed ID: 7715475
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The impact of a monophasic continuous estro-progestogenic treatment on Latin American menopausal women.
    Bassol S; Carranza-Lira S; Celis-Gonzalez C; Santoyo S; Murillo A; Martinez N; Santos J; Llaca V; de la Loza FR; Zarain J; da Fonseca AM; Camargos AF; Baracat EC; da Sá MF; Bayo J; Adaro L; Gurucharri C; Murga M; Siseles N; Sayegh F; Tempone A; Tempone LM; Tozzini RI; Boccanera R; Naranjo C; Sanchez F; Gomez G; Blanco S; Reyes-Marquez R; Albrecht G; Rios PC
    Maturitas; 2005 Mar; 50(3):189-95. PubMed ID: 15734600
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tibolone for the treatment of moderate to severe vasomotor symptoms and genital atrophy in postmenopausal women: a multicenter, randomized, double-blind, placebo-controlled study.
    Swanson SG; Drosman S; Helmond FA; Stathopoulos VM
    Menopause; 2006; 13(6):917-25. PubMed ID: 17006377
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tibolone: new preparation. Menopausal symptoms: oestrogen-progestogen combinations are still the reference treatment.
    Prescrire Int; 2002 Jun; 11(59):79-82. PubMed ID: 12068842
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Isoflavone treatment for acute menopausal symptoms.
    Cheng G; Wilczek B; Warner M; Gustafsson JA; Landgren BM
    Menopause; 2007; 14(3 Pt 1):468-73. PubMed ID: 17290160
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.